Skip to main content
Top
Published in: BMC Women's Health 1/2015

Open Access 01-12-2015 | Research article

Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland

Authors: Pauline Duke, Marshall Godwin, Samuel Ratnam, Lesa Dawson, Daniel Fontaine, Adrian Lear, Martha Traverso-Yepez, Wendy Graham, Mohamad Ravalia, Gerry Mugford, Andrea Pike, Jacqueline Fortier, Mandy Peach

Published in: BMC Women's Health | Issue 1/2015

Login to get access

Abstract

Background

Cervical cancer is highly preventable and treatable if detected early through regular screening. Women in the Canadian province of Newfoundland & Labrador have relatively low rates of cervical cancer screening, with rates of around 40 % between 2007 and 2009. Persistent infection with oncogenic human papillomavirus (HPV) is a necessary cause for the development of cervical cancer, and HPV testing, including self-sampling, has been suggested as an alternative method of cervical cancer screening that may alleviate some barriers to screening. Our objective was to determine whether offering self-collected HPV testing screening increased cervical cancer screening rates in rural communities.

Methods

During the 2-year study, three community-based cohorts were assigned to receive either i) a cervical cancer education campaign with the option of HPV testing; ii) an educational campaign alone; iii) or no intervention. Self-collection kits were offered to eligible women at family medicine clinics and community centres, and participants were surveyed to determine their acceptance of the HPV self-collection kit. Paired proportions testing for before-after studies was used to determine differences in screening rates from baseline, and Chi Square analysis of three dimensional 2 × 2 × 2 tables compared the change between communities.

Results

Cervical cancer screening increased by 15.2 % (p < 0.001) to 67.4 % in the community where self-collection was available, versus a 2.9 % increase (p = 0.07) in the community that received educational campaigns and 8.5 % in the community with no intervention (p = 0.193). The difference in change in rates was statistically significant between communities A and B (p < 0.001) but not between communities A and C (p = 0.193). The response rate was low, with only 9.5 % (168/1760) of eligible women opting to self-collect for HPV testing. Of the women who completed self-collection, 15.5 % (26) had not had a Pap smear in the last 3 years, and 88.7 % reported that they were somewhat or very satisfied with self-collection.

Conclusions

Offering self-collected HPV testing increased the cervical cancer screening rate in a rural NL community. Women who completed self-collection had generally positive feelings about the experience. Offering HPV self-collection may increase screening compliance, particularly among women who do not present for routine Pap smears.
Literature
1.
go back to reference Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.CrossRefPubMed Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.CrossRefPubMed
2.
3.
go back to reference Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180(5):1415–23.CrossRefPubMed Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180(5):1415–23.CrossRefPubMed
4.
go back to reference Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001;357(9271):1831–6.CrossRefPubMed Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001;357(9271):1831–6.CrossRefPubMed
5.
go back to reference Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001;164(7):1017–25.PubMedPubMedCentral Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001;164(7):1017–25.PubMedPubMedCentral
6.
go back to reference Ingemann-Hansen O, Lidang M, Niemann I, Dinesen J, Baandrup U, Svanholm H, et al. Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark. Br J Cancer. 2008;98(7):1292–4.CrossRefPubMedPubMedCentral Ingemann-Hansen O, Lidang M, Niemann I, Dinesen J, Baandrup U, Svanholm H, et al. Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark. Br J Cancer. 2008;98(7):1292–4.CrossRefPubMedPubMedCentral
7.
go back to reference Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchaward J, Gilbert J, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675–83.CrossRefPubMed Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchaward J, Gilbert J, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675–83.CrossRefPubMed
8.
go back to reference Racey CS, Withrow DR, Gesink D. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Publ Health. 2013;104(2):e159–66. Racey CS, Withrow DR, Gesink D. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Publ Health. 2013;104(2):e159–66.
9.
go back to reference Lazcano-Ponce E, Tibor Lorincz A, Cruz-Valdez A, Salmeron J, Uribe P, Velasco-Mondragon E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378(9806):1868–73.CrossRefPubMed Lazcano-Ponce E, Tibor Lorincz A, Cruz-Valdez A, Salmeron J, Uribe P, Velasco-Mondragon E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378(9806):1868–73.CrossRefPubMed
10.
go back to reference Wikstrom I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011;105(3):337–9.CrossRefPubMedPubMedCentral Wikstrom I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011;105(3):337–9.CrossRefPubMedPubMedCentral
11.
go back to reference Mayrand MH, Duarte-Franco E, Coutlée F, Rodrigues I, Walter SD, Ratnam S, et al. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). Int J Cancer. 2006;119(3):615–23.CrossRefPubMed Mayrand MH, Duarte-Franco E, Coutlée F, Rodrigues I, Walter SD, Ratnam S, et al. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). Int J Cancer. 2006;119(3):615–23.CrossRefPubMed
12.
go back to reference Mayrand MH, Duarte-Franco E, Rodrigues I, Wlater SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. NEJM. 2007;357:1579–88.CrossRefPubMed Mayrand MH, Duarte-Franco E, Rodrigues I, Wlater SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. NEJM. 2007;357:1579–88.CrossRefPubMed
13.
go back to reference Ronco G, Killner J, Elfstrom KM, Tunsi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials. Lancet. 2014;383(9916):524–32.CrossRefPubMed Ronco G, Killner J, Elfstrom KM, Tunsi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials. Lancet. 2014;383(9916):524–32.CrossRefPubMed
14.
go back to reference Iqidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, Sideri M. Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities. J Womens Health (Larchmt). 2011;20(3):397–402.CrossRef Iqidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, Sideri M. Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities. J Womens Health (Larchmt). 2011;20(3):397–402.CrossRef
15.
go back to reference Seehusen DA, Dr J, Earwood JS, Sethuraman SN, Cornali J, Gillespie K, et al. Improving women’s experience during speculum examinations at routine gynaecological visits: randomised clinical trial. BMJ. 2006;333(7560):171.CrossRefPubMedPubMedCentral Seehusen DA, Dr J, Earwood JS, Sethuraman SN, Cornali J, Gillespie K, et al. Improving women’s experience during speculum examinations at routine gynaecological visits: randomised clinical trial. BMJ. 2006;333(7560):171.CrossRefPubMedPubMedCentral
16.
go back to reference Larsen M, Oldeide CC, Malterud K. Not so bad after all… Women’s experiences of pelvic examinations. Fam Pract. 1997;14(2):148–52.CrossRefPubMed Larsen M, Oldeide CC, Malterud K. Not so bad after all… Women’s experiences of pelvic examinations. Fam Pract. 1997;14(2):148–52.CrossRefPubMed
17.
18.
go back to reference Abraham J, Stenger M. Cobas HPV test for first-line screening for cervical cancer. J Commun Support Oncol. 2014;12(5):156–7.CrossRef Abraham J, Stenger M. Cobas HPV test for first-line screening for cervical cancer. J Commun Support Oncol. 2014;12(5):156–7.CrossRef
19.
go back to reference Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14:596.CrossRefPubMedPubMedCentral Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14:596.CrossRefPubMedPubMedCentral
20.
go back to reference Levi JE, Longatto-Filho A, Eluf-Neto J, Rodrigues CL, Oliveira CM, Carloni AC, et al. Evaluation of HPV molecular tests in primary screening for cervical cancer in Brazil. OJOG. 2014;4(8):470–8.CrossRef Levi JE, Longatto-Filho A, Eluf-Neto J, Rodrigues CL, Oliveira CM, Carloni AC, et al. Evaluation of HPV molecular tests in primary screening for cervical cancer in Brazil. OJOG. 2014;4(8):470–8.CrossRef
21.
go back to reference Smith KB, Humphreys JS, Wilson MG. Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research? Aust J Rural Health. 2008;16(2):56–66.CrossRefPubMed Smith KB, Humphreys JS, Wilson MG. Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research? Aust J Rural Health. 2008;16(2):56–66.CrossRefPubMed
22.
go back to reference Sabesan S, Piliouras P. Disparity in cancer survival between urban and rural patients – how can clinicians help reduce it? Rural Remote Health. 2009;9(3):1146.PubMed Sabesan S, Piliouras P. Disparity in cancer survival between urban and rural patients – how can clinicians help reduce it? Rural Remote Health. 2009;9(3):1146.PubMed
23.
go back to reference Shell R, Tudiver F. Barriers to cancer screening by rural Appalachian primary care providers. J Rural Health. 2004;20(4):368–73.CrossRefPubMed Shell R, Tudiver F. Barriers to cancer screening by rural Appalachian primary care providers. J Rural Health. 2004;20(4):368–73.CrossRefPubMed
24.
go back to reference Olson RA, Nichol A, Caron NR, Olivotto IA, Speers C, Chia S, et al. Effect of community population size on breast cancer screening, stage distribution, treatment use and outcomes. Can J Publ Health. 2012;103(1):46–52. Olson RA, Nichol A, Caron NR, Olivotto IA, Speers C, Chia S, et al. Effect of community population size on breast cancer screening, stage distribution, treatment use and outcomes. Can J Publ Health. 2012;103(1):46–52.
25.
go back to reference Rosenbaum AJ, Gage JC, Alfaro KM, Ditzian LR, Maza M, Scarinci IC, et al. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynecol Obstet. 2014;126(2):156–60.CrossRef Rosenbaum AJ, Gage JC, Alfaro KM, Ditzian LR, Maza M, Scarinci IC, et al. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynecol Obstet. 2014;126(2):156–60.CrossRef
26.
go back to reference Tisci S, Shen YH, Fife D, Huang J, Goycoolea J, Ma CP, et al. Patient acceptance of self-sampling for human papillomavirus in rural China. J Low Genit Tract Dis. 2003;7(2):107–16.CrossRefPubMed Tisci S, Shen YH, Fife D, Huang J, Goycoolea J, Ma CP, et al. Patient acceptance of self-sampling for human papillomavirus in rural China. J Low Genit Tract Dis. 2003;7(2):107–16.CrossRefPubMed
28.
go back to reference Statistics Canada. 2006 Community Profiles. In: 2006 Census. Statistics Canada Catalogue no. 92-591-XWE. 2006. Statistics Canada. 2006 Community Profiles. In: 2006 Census. Statistics Canada Catalogue no. 92-591-XWE. 2006.
29.
go back to reference Statistics Canada. 2011 Community Profiles. In: 2011 Census. Statistics Canada Catalogue no. 98-316-XWE. 2011. Statistics Canada. 2011 Community Profiles. In: 2011 Census. Statistics Canada Catalogue no. 98-316-XWE. 2011.
30.
go back to reference Canadian Partnership Against Cancer. Cervical cancer screening in Canada: monitoring program performance 2006–2008. Toronto: Canadian Partnership Against Cancer; 2011. Canadian Partnership Against Cancer. Cervical cancer screening in Canada: monitoring program performance 2006–2008. Toronto: Canadian Partnership Against Cancer; 2011.
31.
go back to reference Canadian Partnership Against Cancer. Cervical cancer screening in Canada: monitoring performance 2009–2011. Toronto: Canadian Partnership Against Cancer; 2013. Canadian Partnership Against Cancer. Cervical cancer screening in Canada: monitoring performance 2009–2011. Toronto: Canadian Partnership Against Cancer; 2013.
32.
go back to reference Castle PE, Rausa A, Walls T, Gravitt PE, Patridge EE, Olivo V, et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med. 2011;52(6):452–5.CrossRefPubMedPubMedCentral Castle PE, Rausa A, Walls T, Gravitt PE, Patridge EE, Olivo V, et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med. 2011;52(6):452–5.CrossRefPubMedPubMedCentral
35.
go back to reference Lynn B, Olatunbosun T, Wu C, Barker T. Update on breast cancer screening: literature review and environmental scan. St. John’s: Faculty of Medicine, Memorial University of Newfoundland; 2011. Lynn B, Olatunbosun T, Wu C, Barker T. Update on breast cancer screening: literature review and environmental scan. St. John’s: Faculty of Medicine, Memorial University of Newfoundland; 2011.
36.
go back to reference Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial. Br J Cancer. 2011;104(2):248–54.CrossRefPubMed Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial. Br J Cancer. 2011;104(2):248–54.CrossRefPubMed
Metadata
Title
Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland
Authors
Pauline Duke
Marshall Godwin
Samuel Ratnam
Lesa Dawson
Daniel Fontaine
Adrian Lear
Martha Traverso-Yepez
Wendy Graham
Mohamad Ravalia
Gerry Mugford
Andrea Pike
Jacqueline Fortier
Mandy Peach
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2015
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-015-0206-1

Other articles of this Issue 1/2015

BMC Women's Health 1/2015 Go to the issue